MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejim.2019.07.016

Медицинская библиотека · European journal of internal medicine · 2019

Cytopenia induced by low-dose methotrexate: An analysis of 433 cases from the French pharmacovigilance database.

Lalevée Sophie, Lebrun-Vignes Bénédicte, Simon Corinne, Laugier Delphine, Fardet Laurence, French Network of Regional Centres of Pharmacovigilance

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Up to 5% of individuals exposed to low-dose methotrexate (MTX) (i.e., ≤30 mg/week) may develop cytopenia. However, MTX-induced cytopenia have been poorly described.

MATERIAL AND

METHODS

All cases of cytopenia (i.e., anaemia, leukopenia, thrombocytopenia, bi- or pancytopenia) in patients receiving low-dose MTX reported to the French pharmacovigilance database during 2006-2016 were analysed. Three groups were defined: cytopenia due to MTX medication errors (e.g., daily rather than weekly administration), cytopenia in people receiving several medications including MTX, cytopenia in people receiving only MTX.

RESULTS

433 cases were analysed. Eighty-four cases (19.4%) were due to medication errors, 180 (41.6%) occurred in individuals exposed both to MTX and other drugs, and 169 (39.0%) occurred in individuals only exposed to MTX. By comparison to other patients, those with cytopenia due to medication errors were older (74 ± 13 vs 69 ± 15 years, p = 0.002), received more frequently MTX orally (92.9% vs 65.3%, p<0.001) and had more frequently pancytopenia (71.4% vs 54.4%, p = 0.005). By comparison to individuals exposed to multiple drugs (n = 180), those exposed only to MTX (n = 169) were older (71 ± 15 vs 67 ± 14, p = 0.02), and had more often pancytopenia (62.7% vs 46.7%, p = 0.001). Among those only exposed to MTX, most cases (n = 140, 82.8%) were considered as toxic rather than idiosyncratic reactions and a trigger (e.g. diarrhoea) was found in 59.3% of those cases. Overall 30 (6.9%) deaths occurred, including 8 in the "medication error" group and 8 in the "MTX only" group.

CONCLUSION

These data may be useful for defining optimal biological monitoring of patients prescribed low-dose MTX.

Для цитирования: Lalevée Sophie, Lebrun-Vignes Bénédicte, Simon Corinne, Laugier Delphine, Fardet Laurence, French Network of Regional Centres of Pharmacovigilance. Cytopenia induced by low-dose methotrexate: An analysis of 433 cases from the French pharmacovigilance database.. European journal of internal medicine. 2019. DOI: 10.1016/j.ejim.2019.07.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.